FDA barks at Lilly dog-drug promo (The Indianapolis Star)
FDA says Lilly's new separation-anxiety drug for dogs is 'misleading;' asks company to immediately stop.

Exelon Patch is First Approved by FDA to Treat Alzheimer s Disease (Senior Journal)
July 9, 2007 Exelon Patch (rivastigmine) has received the first worldwide approval in the United States by the Food and Drug Administration of an innovative way to deliver an effective medicine for mild to moderate Alzheimer's disease patients through a skin patch instead of an oral capsule, according to a news release by the drug company Novartis.

New, Free White Paper Details Compliance Requirements for Pharmaceutical, Medical Device Manufacturers (PR Newswire via Yahoo! Finance)
A new, free white paper, detailing critical industrial sterilization and contamination control programs and compliance challenges in the pharmaceutical and medical device manufacturing industries is now available for download at http://www.microtestlabs.com/environmentpaper.